Skip to main content

Table 3 Operative data, postoperative complications and deaths of each groups in the training cohort

From: Anatomical sites (Takasaki’s segmentation) predicts the recurrence-free survival of hepatocellular carcinoma

 

Single segment-HCC (n = 151)

Multiple segments-HCC (n = 60)

Single segment vs Multiple segments (P-value)

Variables

Left segment (n = 64)

Middle segment (n = 28)

Right segment (n = 58)

Caudate area (n = 1)

Duration operation (min)

205.2 ± 83.8

201.4 ± 70.3

203.4 ± 84.3

620

241.0 ± 86.5

0.017

Blood loss (ml)

283.5 ± 356.8

336.0 ± 240.3

321.6 ± 312.1

300

411.8 ± 486.9

0.185

Blood transfusion

     

0.635

 Yes

7 (10.9%)

9 (32.1%)

10 (17.2%)

0

12 (20.0%)

 No

57 (89.1%)

19 (67.9%)

48 (82.8%)

1 (100.0%)

48 (80.0%)

Surgical margin (cm)

     

0.470

 < 1.0

20 (31.3%)

4 (14.3%)

9 (15.5%)

0

16 (22.7%)

 ≥ 1.0

44 (68.7%)

24 (85.7%)

49 (84.5%)

1 (100.0%)

44 (77.3%)

Overall complications

17 (26.6%)

7 (25.0%)

14 (17.2%)

0 (0%)

14 (23.3%)

0.781

 Wound infection (GradeI)

3 (4.7%)

1 (3.6%)

3 (5.2%)

0 (0%)

3 (5.0%)

 Ascites (GradeI)

9 (14.1%)

3 (10.7%)

8 (13.8%)

0 (0%)

6 (10.0%)

 Acute hepatic failure (GradeIV)

1 (1.6%)

0 (0%)

0 (0%)

0 (0%)

1 (1.7%)

 Pulmonary inflammation (GradeII)

3 (4.7%)

3 (10.7%)

3 (5.2%)

0 (0%)

4 (6.7%)

 Haemorrhage (Grade IV)

1 (1.6%)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

In-hospital mortality

2 (3.1%)

0 (0%)

0 (0%)

0 (0%)

1 (1.7%)

0.850